IMR Press / CEOG / Special Issues / endometrial_polyps

Clinical Management of Endometrial Polyps

Submission deadline: 28 August 2023
Special Issue Editors
  • Oronzo Ruggiero Ceci, MD
    San Camillo Center Outpatient Clinic - 70121 Bari, Italy
    Interests: hysteroscopy; cancer prevention; menopause; endocrinological gynecology; contraception
  • Mario Franchini, MD
    Demetra IVF Center-Villa Cherubini, Florence, Italy
    Interests: hysteroscopy; infertility; contraception; biomedical technologies; public health
Special Issue Information

Dear Colleagues,

Endometrial polyps are defined as a single or multiple localized overgrowth, sessile or pedunculate, of the endometrial glands and stroma around a vascular core protruding from the surface of the endometrium. Prevalence is reported to be between 7.8% to 34.9%.

Endometrial polyps can occur in reproductive age in patients with infertility or in premenopausal and postmenopausal patients with abnormal uterine bleeding. Sometimes asymptomatic, they can occasionally be diagnosed by ultrasound.

Clinical management of endometrial polyps consists in their removal, with hysteroscopic polypectomy representing the gold standard. Hysteroscopic technology makes it possible to perform a polypectomy in an office setting using various techniques such as mechanical removal with micro-scissors and grasping forceps, cutting with a bipolar electrode, or via tissue removal system. Each technique provides the necessary tissue for pathological examination. Although uncommon, both atypical hyperplasia and endometrial cancer may originate from endometrial polyps (within 0% to 12.9%).

The recurrence of endometrial polyps depends on the technique being used as well as on the pathogenesis of the pathology. Endometrial polyps do not represent a homogeneous pathogenesis: some depend on an ovarian steroid imbalance while others are of an inflammatory nature. This variance is reflected in different symptoms, oncologic consequences, and recurrence.

Management of endometrial polyps may be conservative, with spontaneous regression accounting for up to 25% of cases. Smaller polyps (< 10 mm) are more likely to regress, and asymptomatic postmenopausal polyps are unlikely to be malignant. In these cases, the observation must be discussed with the patient.

Dr. Oronzo Ruggiero Ceci and Dr. Mario Franchini

Guest Editors

Keywords
endometrial polyp
hysteroscopic management
malignancy in endometrial polyp
endometrial polyp recurrence
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top